产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF12218, RRID:AB_2845023.
展开/折叠
Cellular zinc finger anti NF kappa B protein; Cellular zinc finger anti-NF-kappa-B protein; CEZANNE; HGNC:16683; OTU domain containing protein 7B; OTU domain-containing protein 7B; OTU7B_HUMAN; OTUD7B; ZA20D1; Zinc finger A20 domain containing protein 1; Zinc finger A20 domain-containing protein 1; Zinc finger protein Cezanne;
抗原和靶标
Widely expressed. Abundant in kidney, heart and fetal liver. Expressed differentially among B-cells at distinct developmental stages. Higher expression seen in primary immature B-cells as compared to the mature cells.
- Q6GQQ9 OTU7B_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MTLDMDAVLSDFVRSTGAEPGLARDLLEGKNWDVNAALSDFEQLRQVHAGNLPPSFSEGSGGSRTPEKGFSDREPTRPPRPILQRQDDIVQEKRLSRGISHASSSIVSLARSHVSSNGGGGGSNEHPLEMPICAFQLPDLTVYNEDFRSFIERDLIEQSMLVALEQAGRLNWWVSVDPTSQRLLPLATTGDGNCLLHAASLGMWGFHDRDLMLRKALYALMEKGVEKEALKRRWRWQQTQQNKESGLVYTEDEWQKEWNELIKLASSEPRMHLGTNGANCGGVESSEEPVYESLEEFHVFVLAHVLRRPIVVVADTMLRDSGGEAFAPIPFGGIYLPLEVPASQCHRSPLVLAYDQAHFSALVSMEQKENTKEQAVIPLTDSEYKLLPLHFAVDPGKGWEWGKDDSDNVRLASVILSLEVKLHLLHSYMNVKWIPLSSDAQAPLAQPESPTASAGDEPRSTPESGDSDKESVGSSSTSNEGGRRKEKSKRDREKDKKRADSVANKLGSFGKTLGSKLKKNMGGLMHSKGSKPGGVGTGLGGSSGTETLEKKKKNSLKSWKGGKEEAAGDGPVSEKPPAESVGNGGSKYSQEVMQSLSILRTAMQGEGKFIFVGTLKMGHRHQYQEEMIQRYLSDAEERFLAEQKQKEAERKIMNGGIGGGPPPAKKPEPDAREEQPTGPPAESRAMAFSTGYPGDFTIPRPSGGGVHCQEPRRQLAGGPCVGGLPPYATFPRQCPPGRPYPHQDSIPSLEPGSHSKDGLHRGALLPPPYRVADSYSNGYREPPEPDGWAGGLRGLPPTQTKCKQPNCSFYGHPETNNFCSCCYREELRRREREPDGELLVHRF
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - Q6GQQ9 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K30 | Ubiquitination | Uniprot | |
S55 | Phosphorylation | Uniprot | |
T65 | Phosphorylation | Uniprot | |
T76 | Phosphorylation | Uniprot | |
K93 | Ubiquitination | Uniprot | |
S100 | Phosphorylation | Uniprot | |
S103 | Phosphorylation | Uniprot | |
S104 | Phosphorylation | Uniprot | |
S105 | Phosphorylation | Uniprot | |
S149 | Phosphorylation | Uniprot | |
S159 | Phosphorylation | Uniprot | |
Y218 | Phosphorylation | Uniprot | |
K223 | Ubiquitination | Uniprot | |
K256 | Ubiquitination | Uniprot | |
K263 | Ubiquitination | Uniprot | |
T371 | Phosphorylation | Uniprot | |
K372 | Ubiquitination | Uniprot | |
K385 | Ubiquitination | Uniprot | |
K397 | Ubiquitination | Uniprot | |
S449 | Phosphorylation | Uniprot | |
T451 | Phosphorylation | Uniprot | |
S453 | Phosphorylation | Uniprot | |
S460 | Phosphorylation | Uniprot | |
T461 | Phosphorylation | Uniprot | |
S464 | Phosphorylation | Uniprot | |
S467 | Phosphorylation | Uniprot | |
S471 | Phosphorylation | Uniprot | |
S501 | Phosphorylation | Uniprot | |
K505 | Ubiquitination | Uniprot | |
S508 | Phosphorylation | Uniprot | |
K511 | Ubiquitination | Uniprot | |
K531 | Ubiquitination | Uniprot | |
T547 | Phosphorylation | Uniprot | |
S555 | Phosphorylation | Uniprot | |
S633 | Phosphorylation | Uniprot | |
K644 | Ubiquitination | Uniprot | |
K651 | Ubiquitination | Uniprot | |
K665 | Ubiquitination | Uniprot | |
K666 | Ubiquitination | Uniprot | |
R700 | Methylation | Uniprot | |
S745 | Phosphorylation | Uniprot | |
Y779 | Phosphorylation | Uniprot |
研究背景
Negative regulator of the non-canonical NF-kappa-B pathway that acts by mediating deubiquitination of TRAF3, an inhibitor of the NF-kappa-B pathway, thereby acting as a negative regulator of B-cell responses. In response to non-canonical NF-kappa-B stimuli, deubiquitinates 'Lys-48'-linked polyubiquitin chains of TRAF3, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Negatively regulates mucosal immunity against infections (By similarity). Deubiquitinates ZAP70, and thereby regulates T cell receptor (TCR) signaling that leads to the activation of NF-kappa-B. Plays a role in T cell homeostasis and is required for normal T cell responses, including production of IFNG and IL2 (By similarity). Mediates deubiquitination of EGFR. Has deubiquitinating activity toward 'Lys-11', 'Lys-48' and 'Lys-63'-linked polyubiquitin chains. Has a much higher catalytic rate with 'Lys-11'-linked polyubiquitin chains (in vitro); however the physiological significance of these data are unsure. Hydrolyzes both linear and branched forms of polyubiquitin.
Phosphorylated by EGFR.
Cytoplasm. Nucleus.
Note: Shuttles be cytoplasm and the nucleus in a XPO1/CRM1-dependent manner.
Widely expressed. Abundant in kidney, heart and fetal liver. Expressed differentially among B-cells at distinct developmental stages. Higher expression seen in primary immature B-cells as compared to the mature cells.
Interacts with ZAP70 in activated T cells, but not in resting T cells. Interacts with TRAF3 (By similarity). Interacts with TRAF6. Interacts with PARK7, leading to inhibit deubiquitinase activity. Interacts with EGFR, ITCH and NEDD4.
The protein undergoes a significant conformation change upon binding to ubiquitinated substrates. The loop that precedes the active site is in an autoinhibitory conformation in the apoprotein. Ubiquitin binding leads to a conformation change; the loop is stabilized in a catalytically competent conformation with the result that the active site Cys can form the reaction state intermediate.
Belongs to the peptidase C64 family.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.